A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults
Clinical trial NCT03713086 · COMPLETED
Trial details
- NCT number
- NCT03713086
- Sponsor
- CureVac
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-12
- Primary completion
- 2021-11-23
- Enrollment
- 53
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.